Jiansong Ji
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 14
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 27
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 38
-
- Ferroptosis and cancer prognosis 23
- Molecular Biology top 5%
- RNA modifications and cancer 13
-
- Radiomics and Machine Learning in Medical Imaging 22
-
- Hepatocellular Carcinoma Treatment and Prognosis 14
-
- Immune cells in cancer 11
Jiansong Ji
188 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 1.0k
- Biomaterials 614
- Biomedical Engineering 1.7k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 2.4k
Countries citing papers authored by Jiansong Ji
This map shows the geographic impact of Jiansong Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiansong Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiansong Ji more than expected).
Fields of papers citing papers by Jiansong Ji
This network shows the impact of papers produced by Jiansong Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiansong Ji. The network helps show where Jiansong Ji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiansong Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 10 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 15 | |
| 12 | 2023 | 1 | |
| 13 | Rational Design of Biomaterials to Potentiate Cancer Thermal Therapybreakdown → | 2023 | 111 |
| 14 | 2022 | 62 | |
| 15 | 2022 | 17 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 15 | |
| 18 | 2021 | 34 | |
| 19 | 2021 | 18 | |
| 20 | 2020 | 1 |
About Jiansong Ji
Jiansong Ji is a scholar working on Cancer Research, Biomaterials and Hepatology, having authored 202 papers that have together received 5.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (38 papers), Nanoparticle-Based Drug Delivery (27 papers), Ferroptosis and cancer prognosis (23 papers), Radiomics and Machine Learning in Medical Imaging (22 papers), Cancer, Hypoxia, and Metabolism (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), RNA modifications and cancer (13 papers) and Immune cells in cancer (11 papers). The work is most often cited by research in Cancer Research (1.0k citations), Biomaterials (614 citations) and Biomedical Engineering (1.7k citations). Jiansong Ji has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Minjiang Chen, Yongzhong Du, Gaofeng Shu, Qiaoyou Weng, Zhongwei Zhao, Shiji Fang, Zhuang Liu, Bufu Tang, Chenying Lu and Xiaoling Xu. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.